New News information at Pharmaceutical Technology New and updated information from News listed on en-us New News information at Pharmaceutical Technology GSK joins AstraZeneca and Labcyte to develop acoustic mass spectrometry GSK has joined forces with AstraZeneca and Labcyte to combine acoustic liquid dispensing technology with mass spectrometry (MS) for use in high throughput small molecule screening and other drug discovery applications. Thu, 21 Sep 2017 23:00:00 GMT Deals this week: Aspen Global Incorporated, Zhejiang Conba Pharmaceutical, Teva Pharmaceutical Industries Mauritius-based holding company Aspen Global Incorporated (AGI) has signed an agreement with AstraZeneca to acquire the rights to the latter’s anaesthetic treatments portfolio for $555m. Thu, 21 Sep 2017 23:00:00 GMT Novartis’ Rydapt receives approval for two cancer treatments in the EU The European Commission (EC) has approved Novartis’ Rydapt (midostaurin) for two indications in rare, hard-to-treat cancers. Thu, 21 Sep 2017 23:00:00 GMT M&As this week: Catalent, Ultragenyx Pharmaceutical Catalent has announced plans to acquire Cook Pharmica for $950m. Thu, 21 Sep 2017 23:00:00 GMT Recipharm and Roche sign agreement to manufacture solid dose products Swedish pharmaceutical company Recipharm has signed a long-term manufacturing agreement with Roche to produce a wide range of solid dose products. Wed, 20 Sep 2017 23:00:00 GMT Pfizer files lawsuit against J&J’s exclusionary contracts for Remicade Pfizer has filed a lawsuit against Johnson & Johnson (J&J) in the US District Court for the Eastern District of Pennsylvania to ensure patients and providers have access to major, lower-cost biosimilar therapies. Wed, 20 Sep 2017 23:00:00 GMT NICE recommends Bristol-Myers Squibb’s nivolumab for NSCLC patients on NHS The UK National Institute for Health and Care Excellence (NICE) has recommended Bristol-Myers Squibb’s immunotherapy drug Opdivo (nivolumab) for NHS use through the Cancer Drugs Fund (CDF) for the treatment of advanced non-small-cell lung cancer (NSC… Wed, 20 Sep 2017 23:00:00 GMT Zydus and Pharm Aid enter deal for varicella vaccine technology in Russia Indian healthcare company Zydus Cadila has entered an exclusive agreement with Pharm Aid for the technology expertise of varicella vaccine production in Russia to prevent chickenpox. Tue, 19 Sep 2017 23:00:00 GMT Catalent signs agreement to buy Cook Pharmica for $950m US-based company Cook Group has reached an agreement to divest its drug manufacturing division Cook Pharmica to Catalent for $950m. Tue, 19 Sep 2017 23:00:00 GMT New study suggests jet lag drug benefits patients undergoing chemotherapy A recent study conducted by scientists at the Universities of Edinburgh and Aberdeen has suggested that painful side effects from cancer medicines can be managed using melatonin, a drug that helps ease the effects of jet lag. Tue, 19 Sep 2017 23:00:00 GMT Teva to sell assets in global women’s health business for $1.38bn Teva Pharmaceutical Industries has entered two agreements to divest the remaining stake in its specialist global women’s health business for $1.38bn. Mon, 18 Sep 2017 23:00:00 GMT NUS study shows Artemisinin-ALA co-treatment could destroy cancer cells A new study conducted by researchers from the National University of Singapore (NUS) has revealed that the co-treatment using artemisinin and aminolaevulinic acid (ALA) can potentially kill cancer cells and suppress tumour growth with fewer side effe… Mon, 18 Sep 2017 23:00:00 GMT Gates Foundation supports development of Immunocore’s therapeutics for infectious diseases Immunocore has secured up to $40m in investment from Bill & Melinda Gates Foundation to boost the development of soluble T-cell receptor (TCR)-based therapeutics to treat infectious diseases, in particular tuberculosis (TB) and human immunodeficiency… Mon, 18 Sep 2017 23:00:00 GMT Amgen and Allergan’s anti-cancer biosimilar Mvasi receives FDA approval The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) for the treatment of five types of cancer. Sun, 17 Sep 2017 23:00:00 GMT GSK and Innoviva receive positive opinion from CHMP for Trelegy Ellipta to treat COPD The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for marketing authorisation of Trelegy Ellipta as a maintenance treatment in adult patients with moderate-to-severe chronic obst… Sun, 17 Sep 2017 23:00:00 GMT Aspen to acquire remaining rights to AstraZeneca’s anaesthetic medicines Aspen Global Incorporated (AGI) has entered an agreement to acquire all the remaining rights to AstraZeneca’s established anaesthetic treatments for an upfront consideration of $555m. Sun, 17 Sep 2017 23:00:00 GMT Evotec and MaRS Innovation launch new drug-discovery partnership German company Evotec and Canada-based MaRS Innovation (MI) have launched a joint partnership ‘LAB150’ in Toronto, Ontario, Canada. Thu, 14 Sep 2017 23:00:00 GMT Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology. Thu, 14 Sep 2017 23:00:00 GMT M&As this week: Silver Falcon, Adcock Ingram Holdings, Boya Bio-pharmaceutical Group Financial services provider Silver Falcon plans to acquire biotechnology company Hemogenyx Pharmaceuticals (Hemogenyx Pharma) for £8m ($10.5m). Thu, 14 Sep 2017 23:00:00 GMT Bristol-Myers and Halozyme to develop subcutaneous immuno-oncology drugs Bristol-Myers Squibb has entered a global collaboration and licence agreement to use Halozyme Therapeutics’ Enhanze drug-delivery technology for the development of its subcutaneously administered immuno-oncology treatments. Thu, 14 Sep 2017 23:00:00 GMT